All news

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces that it has entered exclusive negotiations with a view to the acquisition of 100% of the capital of a European start-up specialized in the design, manufacture and sale of implants and instruments for spinal surgery.

The Combined General Meeting of Spineway’s shareholders was held upon first notice of meeting on Monday, 8 March 2020, behind closed doors, at the Company’s registered office. The number of shares held by the shareholders represented amounted to 3 232 993 768 shares, i.e., a turnout of 25.79%.

Spineway announces the signature of a partnership with the Italian company Tsunami Medical, pioneer in innovative 3D-printed solutions, for the sale of Twin Peaks interbody cages produced with 3D printers.

Spineway, specialized in the treatment of severe disorders of the spine, announces the first surgery in Thailand with Mont Blanc 3D+ instrumentation as well as the signature of an exclusive distribution agreement for the marketing of its products in Malaysia.

Spineway’s Board of Directors, at a meeting held on 25 January 2021 chaired by Stéphane Le Roux, closed the 2020 annual accounts.

Spineway, specialized in innovative implants for the treatment of disorders of the spinal column (spine), showed a sharp increase in sales for the month of December 2020 (+30% compared with December 2019), allowing it to post revenue of €1 068K for the fourth quarter, up 21% compared with the third quarter of 2020. This positive dynamism brough the Group’s annual revenue to €3 380K and decreased the gap with 2019 (-33%) for a year that was deeply affected by the COVID crisis.

SPINEWAY (ISIN : FR0011398874 – ALSPW), specialized in the treatment of severe disorders of the spine, announced today its 2021 financial calendar.

In keeping with its development strategy, Spineway wishes to be in a position to take advantage of any and all external-growth opportunities that could create value and new synergies. To this end, Spineway decided to launch a new subscription phase for Convertible Bonds with warrants.

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), announces its choice of TUV Rheinland as the notified body for the certification of its implant and instrument product lines. With the European regulations governing medical devices constantly changing and ever more stringent, Spineway thus ensures that it will be able to provide high-quality products consistently.